Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Zalifrelimab (AGEN1884) is a fully human IgG1 monoclonal antibody that targets CTLA-4 (CTLA-4), functioning by antagonizing the CTLA-4-signaling-regulated inhibitory checkpoints of immune cell activation.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Zalifrelimab (AGEN1884) is a fully human IgG1 monoclonal antibody that targets CTLA-4 (CTLA-4), functioning by antagonizing the CTLA-4-signaling-regulated inhibitory checkpoints of immune cell activation. |
Molecular Weight | N/A |
CAS No. | 2148321-69-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Zalifrelimab 2148321-69-9 inhibitor inhibit